|
US5288931A
(en)
*
|
1991-12-06 |
1994-02-22 |
Genentech, Inc. |
Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
|
|
US6177078B1
(en)
|
1995-12-29 |
2001-01-23 |
Medvet Science Pty Limited |
Monoclonal antibody antagonists to IL-3
|
|
JP4327350B2
(ja)
|
1997-11-17 |
2009-09-09 |
マイクロメット アーゲー |
エピトープへの結合能力を保持する結合部位ドメインの同定のための新規方法
|
|
AU773029B2
(en)
|
1999-02-08 |
2004-05-13 |
Medvet Science Pty. Ltd. |
Cytokine-binding domain
|
|
EP1161453A4
(en)
|
1999-02-08 |
2005-01-05 |
Medvet Science Pty Ltd |
CYTOKIN-BINDING DOMAIN
|
|
GB9912350D0
(en)
*
|
1999-05-26 |
1999-07-28 |
European Molecular Biology Lab Embl |
Modified cytokine
|
|
NZ521255A
(en)
|
2000-03-06 |
2007-01-26 |
Univ Kentucky Res Found |
Methods to impair hematologic cancer progenitor cells and compounds related thereto
|
|
FI117667B
(fi)
*
|
2001-07-05 |
2007-01-15 |
Univ Zuerich |
Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä
|
|
RU2005137325A
(ru)
|
2003-05-31 |
2006-09-10 |
Микромет Аг (De) |
Фармацевтическая композиция, содержащая конструкт, специфичный к ерсам
|
|
FR2879605B1
(fr)
|
2004-12-16 |
2008-10-17 |
Centre Nat Rech Scient Cnrse |
Production de formats d'anticorps et applications immunologiques de ces formats
|
|
WO2009070844A1
(en)
|
2007-12-06 |
2009-06-11 |
Csl Limited |
Method of inhibition of leukemic stem cells
|
|
US20100209341A1
(en)
|
2009-02-18 |
2010-08-19 |
Csl Limited |
Treatment of chronic inflammatory conditions
|
|
JP5694923B2
(ja)
|
2009-04-27 |
2015-04-01 |
協和発酵キリン株式会社 |
血液腫瘍治療を目的とした抗ＩＬ−３Ｒα抗体
|
|
EP2436397B1
(en)
|
2009-05-29 |
2017-05-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition containing antagonist of egf family ligand as component
|
|
AU2011217728B2
(en)
|
2010-02-17 |
2013-03-14 |
Csl Limited |
Compositions and methods for targeting type 1 interferon producing cells
|
|
CA2802046C
(en)
|
2010-06-07 |
2018-12-11 |
Stepan Company |
Dilutable biocidal compositions and methods of use
|
|
NZ604510A
(en)
|
2010-08-17 |
2013-10-25 |
Csl Ltd |
Dilutable biocidal compositions and methods of use
|
|
EP2626069A4
(en)
|
2010-10-06 |
2014-03-19 |
Univ Tokyo |
Prophylactic and/or therapeutic agent against lymphedema
|
|
US9155802B2
(en)
|
2010-11-01 |
2015-10-13 |
Symphogen A/S |
Pan-HER antibody composition
|
|
MX347981B
(es)
|
2010-11-01 |
2017-05-22 |
Symphogen As |
Composicion de anticuerpos pan-her.
|
|
EP2658869B1
(en)
|
2010-12-30 |
2019-06-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antigen binding formats for use in therapeutic treatments or diagnostic assays
|
|
AU2012212047A1
(en)
*
|
2011-02-03 |
2013-08-22 |
Xoma Technology Ltd. |
Methods and materials for enhancing functional protein expression in bacteria
|
|
US20160046718A1
(en)
|
2013-03-14 |
2016-02-18 |
Csl Limited |
Agents that neutralize il-3 signalling and uses thereof
|
|
WO2014138805A1
(en)
|
2013-03-14 |
2014-09-18 |
Csl Limited |
Anti il-3r alpha agents and uses thereof
|
|
PE20170255A1
(es)
|
2014-01-24 |
2017-03-22 |
Dana Farber Cancer Inst Inc |
Moleculas de anticuerpo que se unen a pd-1 y usos de las mismas
|
|
PL3119807T3
(pl)
|
2014-03-19 |
2019-09-30 |
Cellectis |
Specyficzne wobec cd123 chimeryczne receptory antygenowe do immunoterapii nowotworów
|
|
SI3148579T1
(sl)
|
2014-05-28 |
2021-07-30 |
Agenus Inc. |
Proti GITR antitelesa in postopki z njihovo uporabo
|
|
US20180134795A1
(en)
|
2014-06-17 |
2018-05-17 |
Cellectis |
Cd123 specific multi-chain chimeric antigen receptor
|
|
WO2015197598A2
(en)
|
2014-06-27 |
2015-12-30 |
Innate Pharma |
Multispecific antigen binding proteins
|
|
JP6822849B2
(ja)
|
2014-06-27 |
2021-01-27 |
イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． |
多重特異的ＮＫｐ４６結合タンパク質
|
|
CN105367657B
(zh)
|
2014-08-14 |
2019-09-13 |
上海生物制品研究所有限责任公司 |
抗her3抗体、其制法及其应用
|
|
EP2990416B1
(en)
|
2014-08-29 |
2018-06-20 |
GEMoaB Monoclonals GmbH |
Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders
|
|
MA40609B1
(fr)
|
2014-09-05 |
2020-05-29 |
Janssen Pharmaceutica Nv |
Agents de liaison cd123 et leurs utilisations
|
|
FI3218005T3
(fi)
|
2014-11-12 |
2023-03-31 |
Seagen Inc |
Glykaanin kanssa vuorovaikutteisia yhdisteitä ja käyttömenetelmiä
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
CN120988137A
(zh)
|
2015-01-23 |
2025-11-21 |
赛诺菲 |
抗cd3抗体、抗cd123抗体和与cd3和/或cd123特异性结合的双特异性抗体
|
|
BR112017013981A2
(pt)
|
2015-01-26 |
2018-01-02 |
Cellectis |
receptores antigênicos quiméricos com uma única cadeia específicos anti-cll1 (sccars) para imunoterapia de câncer
|
|
BR112017023862A2
(pt)
|
2015-05-04 |
2018-07-17 |
Cytomx Therapeutics Inc |
anticorpos anti-cd71, anticorpos anti-cd71 ativáveis, e métodos de uso destes
|
|
TW201709932A
(zh)
|
2015-06-12 |
2017-03-16 |
西雅圖遺傳學公司 |
Ｃｄ１２３抗體及其共軛物
|
|
AU2016284871B2
(en)
|
2015-06-23 |
2022-09-29 |
Innate Pharma |
Multispecific NK engager proteins
|
|
DK3313876T3
(da)
|
2015-06-23 |
2025-04-22 |
Innate Pharma |
Multispecifikke antigenbindende proteiner
|
|
JP6768011B2
(ja)
|
2015-06-23 |
2020-10-14 |
バイエル ファーマ アクチエンゲゼルシャフト |
キネシンスピンドルタンパク質（ｋｓｐ）阻害剤の抗ｃｄ１２３抗体との抗体薬物複合体
|
|
WO2017025323A1
(en)
|
2015-08-11 |
2017-02-16 |
Cellectis |
Cells for immunotherapy engineered for targeting cd38 antigen and for cd38 gene inactivation
|
|
CA3002097A1
(en)
|
2015-11-12 |
2017-05-18 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
WO2017096276A1
(en)
|
2015-12-02 |
2017-06-08 |
Agenus Inc. |
Anti-gitr antibodies and methods of use thereof
|
|
EP3383431A4
(en)
|
2015-12-02 |
2019-08-28 |
Agenus Inc. |
ANTI-GITR ANTIBODIES AND METHOD OF USE THEREOF
|
|
CN108883173B
(zh)
|
2015-12-02 |
2022-09-06 |
阿吉纳斯公司 |
抗体和其使用方法
|
|
MA43389A
(fr)
|
2015-12-02 |
2021-05-12 |
Agenus Inc |
Anticorps anti-ox40 et leurs procédés d'utilisation
|
|
EP3397645B1
(en)
|
2015-12-28 |
2026-03-25 |
Innate Pharma |
Variable regions for nkp46 binding proteins
|
|
WO2017160954A1
(en)
|
2016-03-15 |
2017-09-21 |
Seattle Genetics, Inc. |
Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors
|
|
WO2017214433A1
(en)
|
2016-06-09 |
2017-12-14 |
Seattle Genetics, Inc. |
Combinations of pbd-based antibody drug conjugates with flt3 inhibitors
|
|
TWI790206B
(zh)
*
|
2016-07-18 |
2023-01-21 |
法商賽諾菲公司 |
特異性結合至ｃｄ３和ｃｄ１２３的雙特異性抗體樣結合蛋白
|
|
EP3713959A1
(en)
*
|
2017-11-21 |
2020-09-30 |
Innate Pharma |
Multispecific antigen binding proteins
|
|
KR20210133261A
(ko)
|
2019-02-26 |
2021-11-05 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
Bcma에 결합하는 항원 결합 단백질
|
|
TWI905354B
(zh)
*
|
2020-12-31 |
2025-11-21 |
法商英耐特醫藥公司 |
結合至NKp46及CD123之多功能自然殺手 (NK) 細胞接合體
|
|
WO2022200525A1
(en)
|
2021-03-26 |
2022-09-29 |
Innate Pharma |
Multispecific proteins comprising an nkp46-binding site, a cancer antgienge binding site fused to a cytokine for nk cell engaging
|
|
BR112023025331A2
(pt)
|
2021-06-09 |
2024-02-27 |
Innate Pharma |
Proteína multiespecífica, composição farmacêutica, célula recombinante, ácido nucleico ou conjunto de ácidos nucleicos, uso de uma proteína ou composição, métodos ou uso
|